Back to top
Regonat 40mg Tablet
Regonat 40mg Tablet

Regonat 40mg Tablet

Price 8500 INR/ Bottle

MOQ : 5 Bottles

Regonat 40mg Tablet Specification

  • Storage
  • Store below 30°C
  • Dosage Form
  • tablet
  • Origin of Medicine
  • india
  • Usage
  • Colorectal cancer
  • Salt Composition
  • Regorafenib
  • Indication
  • Colorectal cancer
 
 

Regonat 40mg Tablet About

Regonat 40 mg Tablets


Regonat 40 mg contains the active ingredient regorafenib a targeted cancer treatment that helps slow the growth of cancer cells It is prescribed for colon or rectal cancer certain types of stomach and bowel cancer and liver cancer


Important Information

Consult Your Doctor Before taking Regonat inform your doctor if you have liver disease bleeding disorders severe stomach or bowel problems heart conditions or high blood pressure

Allergy Warning Do not take Regonat if you are allergic to regorafenib or any of its ingredients

Always follow your doctors instructions for dosage and use

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

440mg Hertraz Injection

440mg Hertraz Injection

Price 14500.0 INR / Box

Minimum Order Quantity : 1 Piece

Salt Composition : Trastuzumab

Usage : Hospital, Clinic, Personal

Dosage Form : Injection

Expiration Date : 2028 Years

Piclib 125mg Capsule

Piclib 125mg Capsule

Price 3000.0 INR / Box

Minimum Order Quantity : 5 Boxes

Salt Composition : Palbociclib

Usage : HRpositive, HER2negative advanced or metastatic breast cancer

Dosage Form : Tablet

Expiration Date : 2028 Years

Azel 160mg Tablet

Azel 160mg Tablet

Price 5485.0 INR

Minimum Order Quantity : 5 Pieces

Salt Composition : Enzalutamide

Usage : Advanced prostate cancer

Dosage Form : Capsule

Expiration Date : 2028 Years

Ciclib 125mg Capsule

Ciclib 125mg Capsule

Price 3500.0 INR

Minimum Order Quantity : 5 Bottles

Salt Composition : palbociclib

Usage : HRpositive, HER2negative advanced or metastatic breast cancer

Dosage Form : Tablet

Expiration Date : 2028 Years